Position in EXEL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$51,671,490
+$38,570,097 QoQ
Shares Held
949,669
+210.9% QoQ
Ownership
0.378%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#4
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $896,134,901 across 107 Biotechnology names. EXEL ranks #3 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,671,490 | 949,669 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $13,101,393 | 305,465 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $11,470,223 | 261,698 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $11,359,771 | 275,055 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $11,977,285 | 271,717 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $9,158,855 | 248,073 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $6,667,592 | 200,228 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,420,219 | 170,336 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,214,445 | 143,055 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,688,804 | 155,449 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,434,216 | 143,152 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,626,588 | 120,210 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,648,913 | 138,614 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,462,721 | 126,879 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,427,525 | 151,342 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,551,653 | 162,733 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,489,702 | 167,613 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $3,563,111 | 157,173 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,161,683 | 118,254 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $3,022,660 | 142,983 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $2,516,929 | 138,141 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,849,163 | 126,125 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $3,098,547 | 154,387 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,934,567 | 160,923 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $4,087,814 | 172,191 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $3,584,050 | 208,133 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||